Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STAGE-III' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 522 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sondak, VK
      Adjuvant therapy for melanoma

      CANCER JOURNAL
    2. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Alberts, DS; Hallum, AV; Stratton-Custis, M; Garcia, DJ; Gleason-Guzman, M; Salmon, SE; Santabarbara, P; Niesor, EJ; Floret, S; Bentzen, CL
      Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug

      CLINICAL CANCER RESEARCH
    5. Gillette-Cloven, N; Burger, RA; Monk, BJ; McMeekin, DS; Vasilev, S; DiSaia, PJ; Kohler, MF
      Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    6. Thawer, HA; Houghton, PE
      Effects of electrical stimulation on the histological properties of woundsin diabetic mice

      WOUND REPAIR AND REGENERATION
    7. Carinci, F; Cassano, L; Farina, A; Pelucchi, S; Calearo, C; Modugno, V; Nielsen, I; Api, P; Pastore, A
      Unresectable primary tumor of head and neck: Does neck dissection combinedwith chemoradiotherapy improve survival?

      JOURNAL OF CRANIOFACIAL SURGERY
    8. Tamussino, KF; Gucer, F; Reich, O; Moser, F; Petru, E; Scholz, HS
      Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    9. Vermorken, JB
      The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    10. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    11. Hager, ED; Dziambor, H; Hohmann, D; Muhe, N; Strama, H
      Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    12. Vermorken, JB
      Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    13. Leon, X; Quer, M; Orus, C; Lopez, M; Gras, JR; Vega, M
      Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    14. Kawashiri, S; Kojima, K; Kumagai, S; Nakagawa, K; Yamamoto, E
      Effects of chemotherapy on invasion and metastasis of oral cavity cancer in mice

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    15. Browman, GP; Hodson, DI; Mackenzie, RJ; Bestic, N; Zuraw, L
      Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    16. Dillman, RO; DeLeon, C; Beutel, LD; Barth, NM; Schwartzberg, LS; Spitler, LE; Garfield, DH; O'Connor, AA; Nayak, SK
      Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    17. Markman, M
      Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    18. Choy, H
      Taxanes in combined modality therapy for solid tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    19. Chiara, S; Lionetto, R; Vincenti, M; Bruzzone, M; Nobile, MT; Gadducci, A; Carnino, F; Rosso, R; Conte, P
      Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    20. Ichimura, T; Ishiko, O; Nishimura, S; Kojima, T; Shimura, K
      Primary peritoneal clear cell carcinoma: Excellent results from paclitaxeland carboplatin combination chemotherapy

      ONCOLOGY REPORTS
    21. Matsumoto, Y; Ishiko, O; Nakagawa, E; Sumi, T; Hyun, Y; Ando, Y; Ogita, S
      Pharmacokinetics and pharmacodynamics of serum platinum of gynecologic cancer patients treated with nedaplatin

      ONCOLOGY REPORTS
    22. Adachi, S; Ogasawara, T; Ito, K; Koyama, M; Nagano, T; Suzuki, A; Yamada, T; Nakata, Y; Ozawa, M
      A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer

      ONCOLOGY REPORTS
    23. Adachi, S; Itani, Y; Ito, K; Noda, T; Shintani, M; Saito, K; Furukawa, N; Tomii, Y
      Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer

      ONCOLOGY REPORTS
    24. Tsujinaka, T; Shiozaki, H; Yano, M; Kikkawa, N; Takami, M; Monden, M
      Prognostic factors for recurrence in stage II and III gastric cancer patients receiving a curative resection and postoperative adjuvant chemotherapy

      ONCOLOGY REPORTS
    25. Lewinski, T; Zulawski, M; Turski, C; Pietraszek, A
      Small cell lung cancer I-III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    26. Underhill, CR; Parnis, FX; Highley, MS; Ahern, J; Harper, PG; Hansen, H; Lund, B; Dombernowsky, P; Hirsch, F; Hansen, M; Carmichael, J; Williams, C
      Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer

      ANTI-CANCER DRUGS
    27. Piccart, MJ; Lamb, H; Vermorken, JB
      Current and future potential roles of the platinum drugs in the treatment of ovarian cancer

      ANNALS OF ONCOLOGY
    28. Boccardo, F; Miglietta, L; Bruzzone, M; Rubagotti, A; Locatelli, MC; Ragni, N
      Paclitaxel plus organoplatins: Still the gold standard in advanced ovariancancer?

      ANNALS OF ONCOLOGY
    29. Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Philip, T; Cure, H; Lotz, JP; Chauvin, F; Ferrante, P; Rosti, G
      High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

      ANNALS OF ONCOLOGY
    30. Misset, JL; Vennin, P; Chollet, P; Pouillart, P; Laplaige, P; Frobert, JL; Castera, D; Fabro, M; Langlois, D; Cortesi, E; Lucas, V; Gamelin, E; Laadem, A; Otero, J
      Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

      ANNALS OF ONCOLOGY
    31. Markman, M
      Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?

      ONCOLOGY-NEW YORK
    32. Im, DD; McGuire, WP; Rosenshein, NB
      Contemporary management of ovarian cancer

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    33. Schwartz, S; Patrick, DL; Yueh, B
      Quality-of-life outcomes in the evaluation of head and neck cancer treatments

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    34. Pilati, P; Rossi, CR; Mocellin, S; Foletto, M; Scagnet, B; Pasetto, L; Lise, M
      Multimodal treatment of peritoneal carcinomatosis and sarcomatosis

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    35. Bonaccorsi, P; Ansel, JC; Armstrong, CA
      Management of high-risk melanoma

      DERMATOLOGIC CLINICS
    36. McGuire, WP
      Intraperitoneal therapy for ovarian cancer: A sacrifice bunt

      JOURNAL OF CLINICAL ONCOLOGY
    37. Boardman, CH; Webb, MJ
      Surgery in ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    38. Lehoczky, O; Bagameri, A; Udvary, J; Pulay, T
      Side-effects of paclitaxel therapy in ovarian cancer patents

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    39. Plataniotis, GA; Theofanopoulou, MA
      Treatment of inoperable stage III and IV non-small-cell lung cancer: The 'average' radiotherapist's point of view

      ONKOLOGIE
    40. Ferrigno, R; Novaes, PERD; Pellizzon, ACA; Maia, MAC; Fogarolli, RC; Gentil, AC; Salvajoli, JV
      High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    41. Wilder, RB; Rodriguez, MA; Tucker, SL; Ha, CS; Hess, MA; Cabanillas, FF; Cox, JD
      Radiation therapy after a partial response to chop chemotherapy for aggressive lymphomas

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    42. Murtha, AD; Knox, SJ; Hoppe, RT; Rupnow, BA; Hanson, J
      Long-term follow-up of patients with Stage III follicular lymphoma treatedwith primary radiotherapy at Stanford University

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    43. Nardi, M; De Marco, S; Fabi, A; Aloe, A; Magnani, E; Pacetti, U; Carlini, P; Ruggeri, EM; Cognetti, F
      Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    44. Christian, J; Thomas, H
      Ovarian cancer chemotherapy

      CANCER TREATMENT REVIEWS
    45. Zweemer, RP; Verheijen, RHM; Coebergh, JWW; Jacobs, IJ; van Diest, PJ; Gille, JJP; Skates, S; Menko, FH; Ten Kate, LP; Kenemans, P
      Survival analysis in familial ovarian cancer, a case control study

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    46. Roovers, JPWR; Sijmons, EA; van Leeuwen, JHS; Mol, BWJ; Witteveen, PO; Slee, PHTJ; Heintz, APM
      Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    47. Fornasiero, A; Ghiotto, C; Daniele, O; Favaretto, AG; D'Amanzo, P; Ziade, A
      Neoadjuvant moderately high-dose chemotherapy with rh-G-CSF in locally advanced breast carcinoma

      TUMORI
    48. Lupattelli, M; Maranzano, E; Bellavita, R; Tarducci, R; Latini, R; Castagnoli, P; Bufalari, A; Corgna, E; Pinaglia, D; Rossetti, R; Ribacchi, R; Latini, P
      Adjuvant radiochemotherapy in high-risk rectal cancer results of a prospective non-randomized study

      TUMORI
    49. Deraco, M; Rossi, CR; Pennacchioli, E; Guadagni, S; Somers, DC; Santoro, N; Raspagliesi, F; Kusamura, S; Vaglini, M
      Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: A phase II clinicalstudy

      TUMORI
    50. Hogberg, T; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in ovarian cancer

      ACTA ONCOLOGICA
    51. Morgan, RJ; Doroshow, JH; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasaki, V; Margolin, K; Somlo, G; Alvarnas, J; McNamara, M; Longmate, J; Raschko, J; Chow, W; Vasilev, S; McGonigle, K; Yen, Y
      Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

      BONE MARROW TRANSPLANTATION
    52. Salerno, MG; Ferrandina, G; Greggi, S; Pierelli, L; Menichella, G; Leone, G; Scambia, G; Mancuso, S
      High-dose chemotherapy - High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results

      BONE MARROW TRANSPLANTATION
    53. Bojko, P; Scheulen, ME; Hilger, R; Oberhoff, C; Schindler, AD; Seeber, S
      High-dose chemotherapy with peripheral blood stem cell transplantation forpatients with advanced ovarian cancer

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    54. Zarogoulidis, K; Kontakiotis, T; Hatziapostolou, P; Fachantidou, E; Delis, D; Goutsikas, J; Constantinidis, TC; Athanasiadis, A; Patakas, D
      A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer

      LUNG CANCER
    55. Ratanatharathorn, V; Lorvidhaya, V; Maoleekoonpairoj, S; Phromratanapongse, P; Sirilerttrakul, S; Kraipiboon, P; Cheirsilpa, A; Tangkaratt, S; Srimuninnimit, V; Pattaranutaporn, P
      Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

      LUNG CANCER
    56. Orlando, M; Mandachain, M
      Gemcitabine in ovarian cancer

      SEMINARS IN ONCOLOGY
    57. Ozols, RF
      The current role of gemcitabine in ovarian cancer

      SEMINARS IN ONCOLOGY
    58. Hainsworth, JD; Vokes, EE
      Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    59. Tournigand, C; Louvet, C; Molitor, JL; Dehni, N; Lejeune, V; Sezeur, A; Pigne, A; Marpeau, L; Cady, J; de Gramont, A
      Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    60. Jaeger, W; Ackermann, S; Kessler, H; Katalinic, A; Lang, N
      The effect of bowel resection on survival in advanced epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    61. Homesley, HD; Hall, DJ; Martin, DA; Lewandowski, GS; Vaccarello, L; Nahhas, WA; Suggs, CL; Penley, RG
      Dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients

      GYNECOLOGIC ONCOLOGY
    62. Aoki, Y; Kase, H; Watanabe, M; Sato, T; Kurata, H; Tanaka, K
      Stage III endometrial cancer: Analysis of prognostic factors and failure patterns after adjuvant chemotherapy

      GYNECOLOGIC ONCOLOGY
    63. Eisenkop, SM; Spirtos, NM
      Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival?

      GYNECOLOGIC ONCOLOGY
    64. Eisenkop, SM; Spirtos, NM
      The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    65. Prince, HM; Rischin, D; Quinn, M; Allen, D; Planner, R; Neesham, D; Gates, P; Davison, J
      Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: Results of a Phase I study

      GYNECOLOGIC ONCOLOGY
    66. Markman, M
      Second-line therapy for potentially platinum-sensitive recurrent ovarian cancer: What is optimal treatment?

      GYNECOLOGIC ONCOLOGY
    67. Makhija, S; Leitao, M; Sabbatini, P; Bellin, N; Almadrones, L; Leon, L; Spriggs, DR; Barakat, R
      Complications associated with intraperitoneal chemotherapy catheters

      GYNECOLOGIC ONCOLOGY
    68. Mariani, A; Webb, MJ; Rao, SK; Lesnick, TG; Podratz, KC
      Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer

      GYNECOLOGIC ONCOLOGY
    69. Firat, S; Erickson, B
      Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum

      GYNECOLOGIC ONCOLOGY
    70. Markman, M
      Intraperitoneal drug delivery of antineoplastics

      DRUGS
    71. Polglase, AL; McMurrick, PJ; Tremayne, AB; Bhathal, PS
      Local recurrence after curative anterior resection with principally blunt dissection for carcinoma of the rectum and rectosigmoid

      DISEASES OF THE COLON & RECTUM
    72. Shimada, H; Umehara, S; Monobe, Y; Hachitanda, Y; Nakagawa, A; Goto, S; Gerbing, RB; Stram, DO; Lukens, JN; Matthay, KK
      International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors - A report from the Children's Cancer Group

      CANCER
    73. Papadimitriou, CA; Kouroussis, C; Moulopoulos, LA; Vlahos, G; Rodolakis, A; Kiamouris, C; Diakomanolis, E; Gika, D; Michalas, S; Dimopoulos, MA
      Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

      CANCER
    74. Merkel, S; Mansmann, U; Papadopoulos, T; Wittekind, C; Hohenberger, W; Hermanek, P
      The prognostic inhomogeneity of colorectal carcinomas stage III - A proposal for subdivision of stage III

      CANCER
    75. Corvo, R; Benasso, M; Sanguineti, G; Lionetto, R; Bacigalupo, A; Margarino, G; Pallestrini, E; Merlano, M; Vitale, V; Rosso, R
      Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck - Results from a phase III randomized trial

      CANCER
    76. Mercado, G; Adelstein, DJ; Saxton, JP; Secic, M; Larto, MA; Lavertu, P
      Hypothyroidism - A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma

      CANCER
    77. Giannice, R; Susini, T; Ferrandina, G; Poerio, A; Margariti, PA; Carminati, R; Marana, E; Mancuso, S; Scambia, G
      Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients

      CANCER
    78. Goto, S; Umehara, S; Gerbing, RB; Stram, DO; Brodeur, GM; Seeger, RC; Lukens, JN; Matthay, DK; Shimada, H
      Histopathology (international neuroblastoma pathology classification) and MYCN status in patients with peripheral neuroblastic tumors - A report fromthe children's cancer group

      CANCER
    79. Dunphy, FR; Dunleavy, TL; Harrison, BR; Trinkaus, KM; Kim, HJ; Stack, BC; Needles, B; Boyd, JH
      Induction paclitaxel and carboplatin for patients with head and neck carcinoma - Analysis of 62 patients treated between 1994 and 1999

      CANCER
    80. Mora, J; Cheung, NKV; Chen, LS; Qin, J; Gerald, W
      Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease

      CANCER
    81. Wilder, RB; Rodriguez, MA; Ha, CS; Pro, B; Hess, MA; Cabanillas, F; Cox, JD
      Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

      CANCER
    82. Watanabe, Y; Koi, M; Hemmi, H; Hoshai, H; Noda, K
      A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer

      BRITISH JOURNAL OF CANCER
    83. Vasey, PA; Atkinson, R; Coleman, R; Crawford, M; Cruickshank, M; Eggleton, P; Fleming, D; Graham, J; Parkin, D; Paul, J; Reed, NS; Kaye, SB
      Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

      BRITISH JOURNAL OF CANCER
    84. Mandigers, CMPW; Meijerink, JPP; Mensink, EJBM; Tonnissen, ELRTM; Hebeda, KM; Bogman, MJJT; Raemaekers, JMM
      Lack of correlation between numbers of circulating t(14;18)-positive cellsand response to first-line treatment in follicular lymphoma

      BLOOD
    85. Patte, C; Auperin, A; Michon, J; Behrendt, H; Leverger, G; Frappaz, D; Lutz, P; Coze, C; Perel, Y; Raphael, M; Terrier-Lacombe, MJ
      The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

      BLOOD
    86. Vergote, I; de Wever, I; Tjalma, W; Van Gramberen, M; Decloedt, J; Van Dam, P
      Interval debulking surgery: An alternative for primary surgical debulking?

      SEMINARS IN SURGICAL ONCOLOGY
    87. Shor-Posner, G
      Cognitive function in HIV-1-infected drug users

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    88. Comer, AM; Goa, KL
      Docetaxel - A review of its use in non-small cell lung cancer

      DRUGS & AGING
    89. Messaris, GE; Konstadoulakis, MM; Ricaniadis, N; Leandros, E; Androulakis, G; Karakousis, PC
      Prognostic variables for patients with stage III malignant melanoma

      EUROPEAN JOURNAL OF SURGERY
    90. Krug, LM; Ng, KK; Kris, MG; Miller, VA; Tong, W; Heelan, RT; Leon, L; Leung, D; Kelly, J; Sirotnak, FM
      Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate

      CLINICAL CANCER RESEARCH
    91. Rivera-Luna, R; Lopez-Facundo, NA; Leal-Leal, C; Gomez-Martinez, R; Castellanos-Toledo, A; Olaya, A; Cardenas-Cardos, R; Ruano-Aguilar, J; Calderon-Elvir, C
      Hodgkin's disease stage III. Staging laparotomy with partial splenectomy. Treatment results in children

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    92. Bhatavdekar, JM; Patel, DD; Shah, NG; Vora, HH; Suthar, TP; Chikhlikar, PR; Ghosh, N; Trivedi, TI
      Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: A multivariate analysis

      ANNALS OF SURGICAL ONCOLOGY
    93. Wolfson, AH
      The role of radiotherapy for high-risk endometrial cancer

      SEMINARS IN RADIATION ONCOLOGY
    94. Cardenes, H; Randall, ME
      Integrating radiation therapy in the curative management of ovarian cancer: Current issues and future directions

      SEMINARS IN RADIATION ONCOLOGY
    95. Di Re, F; Baiocchi, G
      Value of lymph node assessment in ovarian cancer: Status of the art at theend of the second millennium

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    96. Ozols, RF
      Optimum chemotherapy for ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    97. Epenetos, AA; Hird, V; Lambert, H; Mason, P; Coulter, C
      Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    98. Ledermann, JA
      High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    99. Poveda, A
      Advanced ovarian cancer: update, remarks and conclusions on optimal therapy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    100. Deppe, G; Baumann, P
      Advances in ovarian cancer chemotherapy

      CURRENT OPINION IN ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:59:11